𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Computational alanine scanning of the 1:1 human growth hormone–receptor complex

✍ Scribed by Shuanghong Huo; Irina Massova; Peter A. Kollman


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
780 KB
Volume
23
Category
Article
ISSN
0192-8651

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The MM‐PBSA (Molecular Mechanics–Poisson–Boltzmann surface area) method was applied to the human Growth Hormone (hGH) complexed with its receptor to assess both the validity and the limitations of the computational alanine scanning approach. A 400‐ps dynamical trajectory of the fully solvated complex was simulated at 300 K in a 101 Å×81 Å×107 Å water box using periodic boundary conditions. Long‐range electrostatic interactions were treated with the particle mesh Ewald (PME) summation method. Equally spaced snapshots along the trajectory were chosen to compute the binding free energy using a continuum solvation model to calculate the electrostatic desolvation free energy and a solvent‐accessible surface area approach to treat the nonpolar solvation free energy. Computational alanine scanning was performed on the same set of snapshots by mutating the residues in the structural epitope of the hormone and the receptor to alanine and recomputing the Δ__G__~binding~. To further investigate a particular structure, a 200‐ps dynamical trajectory of an R43A hormone–receptor complex was simulated. By postprocessing a single trajectory of the wild‐type complex, the average unsigned error of our calculated ΔΔ__G__~binding~ is ∼1 kcal/mol for the alanine mutations of hydrophobic residues and polar/charged residues without buried salt bridges. When residues involved in buried salt bridges are mutated to alanine, it is demonstrated that a separate trajectory of the alanine mutant complex can lead to reasonable agreement with experimental results. Our approach can be extended to rapid screening of a variety of possible modifications to binding sites. © 2002 Wiley Periodicals, Inc. J Comput Chem 23: 15–27, 2002


📜 SIMILAR VOLUMES


Genetic polymorphisms in the human growt
✍ Zefang Ren; Qiuyin Cai; Xiao-Ou Shu; Hui Cai; Jia-Rong Cheng; Wan-Qing Wen; Yu-T 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 1 views

## Abstract ## BACKGROUND In addition to possessing many physiologic functions, human growth hormone‐1 (GH1) has been shown in recent in vitro and in vivo experiments to induce malignant disease, including breast carcinoma. The authors investigated the association of breast carcinoma with genetic

Human growth hormone 1 (GH1) gene expres
✍ Martin Horan; David S. Millar; Jürgen Hedderich; Geraint Lewis; Vicky Newsway; N 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 325 KB 👁 1 views

The proximal promoter region of the human pituitary expressed growth hormone (GH1) gene is highly polymorphic, containing at least 15 single nucleotide polymorphisms (SNPs). This variation is manifest in 40 different haplotypes, the high diversity being explicable in terms of gene conversion, recurr

The vascular endothelial growth factor r
✍ Yan Wu; Andrea T. Hooper; Zhaojing Zhong; Larry Witte; Peter Bohlen; Shahin Rafi 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 692 KB

## Abstract Vascular endothelial growth factor receptor 1 (VEGFR‐1) is present on endothelial cells and subsets of human tumor cells, raising the hypothesis that angiogenic factors may promote tumor growth both by inducing angiogenesis and directly signaling through activation of VEGFR‐1 on tumor c